Related references
Note: Only part of the references are listed.Pharmacological chaperone therapy for Gaucher disease: a patent review
Juan M. Benito et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors with Chaperone Activity
Juan J. Marugan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Polyhydroxylated Bicyclic Isoureas and Guanidines Are Potent Glucocerebrosidase Inhibitors and Nanomolar Enzyme Activity Enhancers in Gaucher Cells
Ana Trapero et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
A Fluorescent sp2-Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution Studies
Zhuo Luan et al.
CHEMBIOCHEM (2010)
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
Richie Khanna et al.
FEBS JOURNAL (2010)
Glycosphingolipids-Nature, Function, and Pharmacological Modulation
Tom Wennekes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N-(n-nonyl)-Deoxynojirimycin
Zhuo Luan et al.
CHEMBIOCHEM (2009)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Rational Design and Synthesis of Highly Potent Pharmacological Chaperones for Treatment of N370S Mutant Gaucher Disease
Guan-Nan Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Isofagomine Induced Stabilization of Glucocerebrosidase
Gregory J. Kornhaber et al.
CHEMBIOCHEM (2008)
Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry
Michael B. Tropak et al.
CHEMBIOCHEM (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Three classes of gluclocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Aminocyclitols as pharmacological chaperones for glucocerebrosidase, a defective enzyme in Gaucher disease
Meritxell Egido-Gabas et al.
CHEMMEDCHEM (2007)
Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention
Zhanqian Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms
Richard A. Steet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Chemical chaperones and permissive temperatures alter the cellular locatization of Gaucher disease associated glucocerebrosidase variants
Anu R. Sawkar et al.
ACS CHEMICAL BIOLOGY (2006)
Rational design and synthesis of highly potent beta-glucocerebrosidase inhibitors
XX Zhu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Share Paper
